Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA Share Price    (TORR)

Here is the latest stock price and chart of Torrent Pharma. For more details, see the Torrent Pharma company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

Mega Webinar on Jan 29th: Will 2021 be a boom or bust?

REFRESH
Live BSE Quotes Jan 22, 2021 (Close)
Price (Rs)2,691.25 Open (Rs) 2,741.30 High (Rs) 2,741.30 Low (Rs) 2,680.00
% Change-1.75 Volume 5,123 Value (Rs) 13,860,722 52-Week H/L 3,040.00 / 1,619.00
Live NSE Quotes Jan 22, 2021 (Close)
Price (Rs)2,690.35 Open (Rs) 2,744.00 High (Rs) 2,744.00 Low (Rs) 2,680.00
% Change-1.77 Volume 246,554 Value (Rs) 663,316,554 52-Week H/L 3,031.20 / 1,583.25
Change
1 Day
-1.75%
1 Month
-1.86%
3 Months
-0.85%
1 Year
34.63%
5 Years (CAGR)*
14.16%
10 Years (CAGR)*
24.77%

* Compound Annual Growth Rate

Valuation
EPS (Rs)* 70.66 P/E Ratio (x) 38.09 Market Cap (Rs m) 455,520.98 P/BV (x) 9.64
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

TORRENT PHARMA Share Price Today:

TORRENT PHARMA last traded price was down 1.8% to Rs 2,691.3 on the BSE. On the NSE, TORRENT PHARMA last traded price was down 1.8% to Rs 2,690.4. The total volume of shares traded was 0.3 m.

Overall, the broader S&P BSE HEALTHCARE Index was down by 1.2%. And the benchmark S&P BSE SENSEX was at 48,878.5 (down 1.5%).

Over the last 30 days, the TORRENT PHARMA share price is up 0.9%. And over the last one year, TORRENT PHARMA share price is up 33.2%.



What else is happening in the markets today? Dig in...


Today's Market

Crucial Week Ahead for the Indian Stock Market(Momentum Moves)

The market scaled new life-time highs this week but it was the bears who took control. The benchmark indices, Sensex and Nifty ended mostly flat for the week but the momentum was in favour of the bears.

Related Views On News

TORRENT PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 27.0% (Quarterly Result Update)

Oct 27, 2020 | Updated on Oct 27, 2020

For the quarter ended September 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 27.0% YoY). Sales on the other hand came in at Rs 20 bn (up 0.6% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 48.6% (Quarterly Result Update)

Jul 31, 2020 | Updated on Jul 31, 2020

For the quarter ended June 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 48.6% YoY). Sales on the other hand came in at Rs 21 bn (up 1.7% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

More Views on News

Most Popular

Why Gold Hit Lower Circuit (Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Time to Book Profits in Pharma Stocks (Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

A Rare Chance to Invest in Potential Multibaggers in 2021 (Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

Smallcap Stocks: Your Best Bet for 2021 and Beyond (Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 8-QTR ANALYSIS

COMPARE TORRENT PHARMA WITH

MARKET STATS